CONCENTRATION OF INFLIXIMAB IN THE NON-INFLAMED MUCOSA AS A PREDICTOR FOR SECONDARY LOSS OF RESPONSE TO INFLIXIMAB FOR CROHN'S DISEASE PATIENTS: A 4-YEAR PROSPECTIVE STUDY

被引：0
|
作者：
Yoshihara, Takeo
Shinzaki, Shinichiro
Amano, Takahiro
Otake, Yuriko
Tani, Mizuki
Iwatani, Shuko
Tsujii, Yoshiki
Hayashi, Yoshito
Inoue, Takahiro
Watabe, Kenji
Iijima, Hideki
Takehara, Tetsuo
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1815
引用
收藏
页码：S1135 / S1135
页数：1
相关论文
共 50 条
  • [1] Biochemical and immunohistochemical analysis of glycosaminoglycans in inflamed and non-inflamed intestinal mucosa of patients with Crohn’s disease
    Celso L. R. Belmiro
    Heitor S. P. Souza
    Celeste C. S. Elia
    Morgana T. L. Castelo-Branco
    Flavia R. Silva
    Rosane L. Machado
    Mauro S. G. Pavão
    International Journal of Colorectal Disease, 2005, 20 : 295 - 304
  • [2] Biochemical and immunohistochemical analysis of glycosaminoglycans in inflamed and non-inflamed intestinal mucosa of patients with Crohn's disease
    Belmiro, CLR
    Souza, HSP
    Elia, CCS
    Castelo-Branco, MTL
    Silva, FR
    Machado, RL
    Pavao, MSG
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2005, 20 (04) : 295 - 304
  • [3] Management of Therapy in a Crohn's Disease Patient With Secondary Loss of Response to Infliximab
    Park, Taeyang
    Skole, Kevin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1805 - S1805
  • [4] Factors associated with the loss of response to infliximab in patients with Crohn's disease
    Sono, Koji
    Yamada, Akihiro
    Yoshimatsu, Yasushi
    Takada, Nobua
    Suzuki, Yasuo
    CYTOKINE, 2012, 59 (02) : 410 - 416
  • [5] An open label study of adalimumab in Crohn's disease patients with a loss of response to infliximab
    Anwar, Malik
    O'Sullivan, Maria
    Ryan, Barbara
    Breslin, Niall
    O'Connor, Humphrey
    O'Morain, Colm
    GASTROENTEROLOGY, 2006, 130 (04) : A662 - A662
  • [6] Bacterial mucosa-associated microbiome in inflamed and proximal non-inflamed ileum of patients with Crohn's disease
    Olaisen, M.
    Flatberg, A.
    Granlund, A. van Beelen
    Royset, E. S.
    Martinsen, T. C.
    Sandvik, A. K.
    Fossmark, R.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S645 - S646
  • [7] A Novel Radiomics Nomogram for the Prediction of Secondary Loss of Response to Infliximab in Crohn's Disease
    Chen, Yueying
    Li, Hanyang
    Feng, Jing
    Suo, Shiteng
    Feng, Qi
    Shen, Jun
    JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 2731 - 2740
  • [8] Altered microRNA expression in inflamed and non-inflamed terminal ileal mucosa of adult patients with active Crohn's disease
    Guo, Zhen
    Wu, Rong
    Gong, Jianfeng
    Zhu, Weiming
    Li, Yi
    Wang, Zhiming
    Li, Ning
    Li, Jieshou
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (01) : 109 - 116
  • [9] Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab
    Peeters, H.
    Louis, E.
    Baert, F.
    Dewit, O.
    Coche, J. C.
    Ferrante, M.
    Lambrecht, G.
    Colard, A.
    Van Gossum, A.
    Bossuyt, P.
    Moreels, T.
    Vander Cruyssen, B.
    Gils, A.
    De Vos, M.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2018, 81 (01) : 15 - 21
  • [10] Efficacy of switching to infliximab in Crohn's disease patients with loss of response to adalimumab
    Peeters, H.
    Louis, E.
    Baert, F.
    Dewit, O.
    Coche, J. -C.
    Ferrante, M.
    Lambrecht, G.
    Colard, A.
    Van Gossum, A.
    Bossuyt, P.
    Moreels, T.
    De Vos, M.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S274 - S274
12345